Research Funding

OnPAR Funding for Scored But Not Awarded NIH Proposals

We would like to inform you about a new initiative called OnPAR (Online Partnership to Accelerate Research).  This was launched by Leidos Life Sciences in March, 2016.  It is a partnership with NIH that offers a new paradigm to provide funding for highly scored but unfunded NIH applications by matching them with interested non-government organizations (NGOs).  Several different scientific areas have previously been funded using this approach, and OnPar has now expanded to include pain research projects.

If you have submitted an application to NIH for pain-related research that was not funded, this may be of interest to you.  If you would like to have your application considered by OnPAR , please visit: for more information.

Additional information from OnPAR:

The application process will take 5 minutes – here:

  1. Basic Registration – here (administrators can also submit for investigators)
  2. Submission of Public Abstract (in English): This is the public abstract that is submitted with your application
  3. Submission of Applications, Peer-Review, and NDA: if there is a match (funders review for interest), then, we request the full application (in original language), the peer-review (in original language) received from the agency (or other agencies) and a signed Non Disclosure Agreement (we provide).  We don’t require investigators to re-write the unfunded application.

Once potential funders review, they will contact the investigator directly to discuss a partnership and funding.

It is free for all investigators to submit their material.

Please register here to receive updates about OnPAR.

Note that OnPAR has also identified other therapeutics areas of interest:

  • Cardiology, Hematology, Oncology, Women’s Healthcare, Gynecological Therapy, Men’s Health, Ophthalmology, Radiology
  • Diabetes and Complications
  • Infectious Diseases
  • Heart & Kidney
  • Cancer: Breast, Lung, Prostate, Brain, Colon, Bone, and others
  • Neurosciences (AD, PD, Amyotrophic Lateral Sclerosis, Multiple Sclerosis, Migraine, Huntingtons)
  • Rheumatoid arthritis, Psoriasis, Systemic lupus erythematosus, Crohn’s disease, Ulcerative colitis, Ankylosing spondylitis, Psoriatic arthritis, Lupus nephritis, Atopic dermatitis
  • Devices
  • Respiratory (COPD, Asthma)
  • Osteoarthritis, Gastroenterology, Endocrine, Heart failure, Neurology
  • Rare Diseases –many: Cystinosis, NF, Epidermosis Bullosa, Huntington, PSP, Alopecia Areata
  • Animal Health

Also of interest are Discovery & Development Platforms:

  • Cell & Gene Therapy, epigenetics, precision medicine, cell & protein science, chemistry and DMPK, and others

The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services  TO UNSUBSCRIBE: send email to Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L   in the message body of the email – You will receive a confirmation email if successful. If you have problems contact   301-435-1309


2018 McKnight Scholar Award


2018 McKnight Scholar Awards

The McKnight Endowment Fund for Neuroscience supports innovative research designed to bring science closer to the day when diseases of the brain can be accurately diagnosed, prevented, and treated. To this end, the McKnight Endowment Fund for Neuroscience invites applications for the 2018 McKnight Scholar Awards.

Background. These awards were established to encourage emerging neuroscientists to focus on disorders of learning and memory. Applicants for the McKnight Scholar Awards must demonstrate interest in solving important problems in relevant areas of neuroscience, including the translation of basic research to clinical neuroscience. Awards are given to exceptional young scientists who hold the M.D. and/or Ph.D. degree and who are in the early stages of establishing an independent laboratory and research career. Traditionally, successful candidates have held faculty positions for at least one year. For the names of previous recipients and their projects, click here. There is no limit on the number of applicants from a single institution.

Eligibility. In this competition, up to six McKnight Scholars will be selected to receive three years of support, beginning July 1, 2018.

Applicants must have:

  • An M.D., Ph.D., or other suitable doctorate
  • A record of meritorious research
  • Evidence of a commitment to a career in neuroscience
  • Full-time appointment at the rank of Assistant Professor, and must have served at that rank for less than four years at the application deadline. Scientists holding other titles such as Research Assistant Professor, Adjunct Assistant Professor, Assistant Professor Research Track, Visiting Professor or Instructor are not eligible, and time spent in service in those ranks does not count against the four years of service for determining eligibility.
  • No more than four years of experience in an independent faculty position (exceptions may be made to allow for parental leave)
  • Documentation that the sponsoring institution has government approval for the applicant to work in the U.S.

Applicants may not:

  • Be employees of the Howard Hughes Medical Institute or of the Intramural Research Program of the National Institutes of Health
  • Apply in more than two rounds of competition
  • Have already been granted tenure
  • Hold another award from the McKnight Endowment Fund

Amount and purpose of support. Each McKnight Scholar will receive $75,000 annually in 2018, 2019, and 2020. Funds may be used in any way that will facilitate development of the Scholar’s research program, but not for indirect costs.

Selection process. A review committee will evaluate applications and invite a select few to interview with the committee. Applicants selected will be notified by mid- to late-March. The interviews are scheduled for Thursday, April 19, 2018, in New York City.  The committee will then recommend candidates to the Board of Directors of the Endowment Fund for final decision. Awards will be announced on or before May 15, 2018.

For application form and guidelines, please visit our website at  Completed applications must arrive no later than January 8, 2018.

American Skin Association Grants Announced

The American Skin Association’s (ASA) 2018 funding opportunities in dermatology have been announced.  ASA seeks to provide funding for top researchers, physicians, and medical students who are dedicated to the field of dermatology.  Through these grants, ASA hopes to broaden understanding and increase knowledge of various skin diseases.

ASA is currently inviting application submissions from medical students and established researchers alike.  The following grants are being offered this year:

  • Milstein Research Scholar Award in  Melanoma/Non-Melanoma Skin Cancer ($60,000)
  • Calder Research Scholar Award in Vitiligo/Pigment Cell Disorders ($60,000)
  • ASA Research Scholar Award in Dermatology ($60,000)
  • Research Grants in the areas of Childhood Skin diseases/Disfigurement, Psoriasis/Inflammatory Skin Diseases, Skin Cancer & Melanoma, and Quality of Life/health Services/Outcomes Studies ($15,000)
  • Hambrick Medical Student Grants for those students working in the area of Melanoma & Skin Cancer ($7,000)


Submission deadline is Sunday, October 1, 2017 at 11:59 EST.  All applications should be completed online at

For submission instructions and award information click here.